(Q36640754)

15 August 2017

The crux of the UGDP. Spurious results and biologically inappropriate data analysis (English)

1 reference

15 August 2017

0 references

C Kilo

1

1 reference

PubMed ID

6989693

15 August 2017

J P Miller

series ordinal

2

1 reference

PubMed ID

6989693

15 August 2017

J R Williamson

series ordinal

3

1 reference

15 August 2017

1 March 1980

1 reference

15 August 2017

1 reference

15 August 2017

18

1 reference

15 August 2017

3

1 reference

15 August 2017

179-185

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00251913

15 August 2017

0 references

cites work

Clinical biostatistics. XXXV. The persistent clinical failures and fallacies of the UGDP study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00251913

Reversible hematologic sequelae of diabetes mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00251913

Refuting the UGDP Conclusion that Insulin Treatment does not Prevent Vascular Complications in Diabetes

21 January 2018

1 reference

12 December 2020

The University Group Diabetes Program. A statistician looks at the mortality results

1 reference

12 December 2020

How good is the statistical evidence against oral hypoglycemic agents?

1 reference

12 December 2020

Letter: The UGDP scandal and cover-up

1 reference

12 December 2020

Diabetes Drugs: Clinical Trial

1 reference

12 December 2020

Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents

1 reference

12 December 2020

"Settling the UGDP Controversy"?

1 reference

12 December 2020

Decisive Factors In the Tolbutamide Controversy

1 reference

12 December 2020

Correlation of serum triglyceride levels and hemoglobin AIc concentrations in diabetes mellitus

1 reference

12 December 2020

The University Group Diabetes Program. A further statistical analysis of the mortality findings

1 reference

12 December 2020

Insulin Treatment and Diabetic Vascular Complications

1 reference

12 December 2020

Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (first of two parts).

1 reference

12 December 2020

The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy

1 reference

12 December 2020

A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)

1 reference

12 December 2020

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

1 reference

12 December 2020

Clinical biostatistics. XXXVI. the persistent biometric problems of the UGDP study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00251913

1 reference

15 August 2017

1 reference

PubMed ID

6989693